IGC Pharma Inc. Revenue 2011–2025
IGC Pharma Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IGC Pharma Inc. revenue for the quarter ending March 31, 2026 was 317000, a 3.94% decrease year-over-year.
- IGC Pharma Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M, a 1.83% increase year-over-year.
- IGC Pharma Inc. annual revenue for 2025 was 1.3 M, a 5.50% decrease from 2024.
- IGC Pharma Inc. annual revenue for 2024 was 1.3 M, a 47.64% increase from 2023.
- IGC Pharma Inc. annual revenue for 2023 was 911000, a 129.47% increase from 2022.
- IGC Pharma Inc. annual revenue for 2022 was 397000.
IGC Pharma Inc. (IGC) — Frequently Asked Questions
IGC Pharma Inc. (IGC) is a publicly traded US company. It has a market capitalization of $22M. In fiscal 2025 it reported revenue of $1M and net income of -$7M. Explore IGC's stock price, financial statements, earnings history, margins and key ratios below.
What is IGC Pharma Inc.'s market cap?
IGC Pharma Inc. (IGC) has a market capitalization of $22M.
What is the IGC stock price?
IGC trades at $0.29 (+3.20% on the day).
How much revenue does IGC Pharma Inc. make?
IGC Pharma Inc. reported revenue of $1M in fiscal 2025.
Is IGC profitable?
In fiscal 2025, IGC Pharma Inc. reported net income of -$7M.